San Francisco Veterans Affairs Medical Center and University of California, San Francisco, 4150 Clement Street, 111W, San Francisco, CA 94121, USA.
Sci Transl Med. 2018 Feb 28;10(430). doi: 10.1126/scitranslmed.aap9927.
Latently infected CD4 T cells are the main barrier to complete clearance of HIV infection, but it is unclear what mechanisms govern latent HIV infection in vivo. To address this question, we developed a new panel of reverse transcription droplet digital polymerase chain reaction (RT-ddPCR) assays specific for different HIV transcripts that define distinct blocks to transcription. We applied this panel of assays to CD4 T cells freshly isolated from HIV-infected patients on suppressive antiretroviral therapy (ART) to quantify the degree to which different mechanisms inhibit HIV transcription. In addition, we measured the degree to which these transcriptional blocks could be reversed ex vivo by T cell activation (using anti-CD3/CD28 antibodies) or latency-reversing agents. We found that the main reversible block to HIV RNA transcription was not inhibition of transcriptional initiation but rather a series of blocks to proximal elongation, distal transcription/polyadenylation (completion), and multiple splicing. Cell dilution experiments suggested that these mechanisms operated in most of the HIV-infected CD4 T cells examined. Latency-reversing agents exerted differential effects on the three blocks to HIV transcription, suggesting that these blocks may be governed by different mechanisms.
潜伏感染的 CD4 T 细胞是彻底清除 HIV 感染的主要障碍,但尚不清楚哪些机制控制体内潜伏的 HIV 感染。为了解决这个问题,我们开发了一组新的逆转录液滴数字聚合酶链反应 (RT-ddPCR) 检测,专门针对不同的 HIV 转录本,定义了不同的转录阻断。我们将该检测面板应用于从接受抑制性抗逆转录病毒疗法 (ART) 的 HIV 感染患者中新鲜分离的 CD4 T 细胞,以量化不同机制抑制 HIV 转录的程度。此外,我们还测量了 T 细胞激活(使用抗 CD3/CD28 抗体)或潜伏逆转剂体外逆转这些转录阻断的程度。我们发现,HIV RNA 转录的主要可逆阻断不是转录起始的抑制,而是一系列近端延伸、远端转录/多聚腺苷酸化(完成)和多个剪接的阻断。细胞稀释实验表明,这些机制在大多数检测到的 HIV 感染的 CD4 T 细胞中起作用。潜伏逆转剂对 HIV 转录的三个阻断有不同的作用,这表明这些阻断可能由不同的机制控制。